If you have been reading about PPARδ agonist and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
== Interactions == Naltrexone, a non-selective opioid receptor antagonist including of the κ-opioid receptor (KOR), blocks the hallucinogenic and physiological effects of salvinorin A in humans. Conversely, the serotonin 5-HT2A receptor antagonist ketanserin was ineffective.
== Risks == Administration of ACAM2000 poses risks and may cause side effects. Most people who have taken the vaccine only report mild reactions. Reactions may include a sore arm, fever, and body aches. Some people may have more serious side effects, including effects that may be life-threatening. According to the FDA-approved prescribing information leaflet, "Common adverse events include inoculation site signs and symptoms, lymphadenitis, and constitutional symptoms, such as malaise, fatigue, fever, myalgia, and headache." These reactions are less frequent in people being revaccinated than those receiving the vaccine for the first time. No known contraindications exist to receiving the vaccine in case of an outbreak emergency. Furthermore, it is recommended that the vaccine should be given to pregnant women who have been exposed to smallpox. "Because the risk of maternal serious illness or death, prematurity, miscarriage, or stillbirth from a smallpox infection are greater than the risk of the vaccination, smallpox vaccine is recommended and should be offered to pregnant women in case of an outbreak emergency."
The evidence that arsenic may be a beneficial nutrient at trace levels below the background to which living organisms are normally exposed has been reviewed. Some organoarsenic compounds found in nature are arsenobetaine and arsenocholine, both being found in many marine organisms. Some As-containing nucleosides (sugar derivatives) are also known. Several of these organoarsenic compounds arise via methylation processes. For example, the mold Scopulariopsis brevicaulis produces significant amounts of trimethylarsine if inorganic arsenic is present. The organic compound arsenobetaine is found in some marine foods such as fish and algae, and also in mushrooms in larger concentrations. In clean environments, the edible mushroom species Cyanoboletus pulverulentus hyperaccumulates arsenic compounds in concentrations reaching 1,300 mg/kg (dry weight). A very unusual set of organoarsenic compounds was found in deer truffles (Elaphomyces spp.). The average person's intake is about 10–50 μg/day. Values about 1000 μg are not unusual following consumption of fish or mushrooms; however, there is little danger in eating fish since this arsenic compound is nearly non-toxic.
The South African general staff judged correctly that if these narrow entry points were seriously contested they had the potential to bottleneck the FAPLA brigades. They opted to launch a counteroffensive at the Lomba River, which was the last of the three rivers FAPLA had to cross before reaching Mavinga. The success of the South African counteroffensive was ensured by the rapid collapse of FAPLA's 47 Infantry Brigade, which was tasked with establishing a bridgehead on the Lomba's southern bank. In conventional terms, the FAPLA brigades theoretically possessed more than enough strength and firepower to dislodge UNITA and the SADF from the Lomba River. But they were inadequately trained or experienced to counter the South African blocking force, which was composed of units selected for their experience in mobile bush warfare, and were outmanoeuvred in the thick foliage cover. The Lomba's swampy environment also hampered coordinated actions and allowed the SADF to isolate and rout each brigade in piecemeal engagements. Between September and October 1987 FAPLA suffered almost 2,000 casualties during several failed river crossings. With much of its bridging equipment destroyed, FAPLA abandoned the offensive and ordered its remaining brigades back to Cuito Cuanavale. The Soviet military mission had suffered 3 dead and at least 1 seriously wounded. The SADF had suffered 17 dead and 41 wounded, as well as the loss of 5 armoured vehicles.
Sources: en.wikipedia.org
== Awards == Hunt has been awarded several honors including the Distinguished Contribution Award from the American Society for Mass Spectrometry in 1994; the Christian B. Anfinsen Award from the Protein Society; the Chemical Instrumentation Award and Field and Franklin Award from the American Chemical Society; the Thomson Medal from the International Mass Spectrometry Society; the Human Proteome Organization's Distinguished Achievement Award in Proteomics, and the Association of Biomolecular Resource Facilities 2007 Award. In addition, he also received the Charles H. Stone Award (American Chemical Society) and the Pehr Edman Award for outstanding achievements in the application of mass spectrometry. He received the Chemical Instrumentation Award sponsored by the American Chemical Society in 1997.
Over the following decade, numerous Half-Life games were canceled, including Episode Three, a version of Half-Life 3, Borealis, a Source 2 VR spin-off, and games developed by Junction Point Studios and Arkane Studios. In 2020, after years of speculation, Valve released Half-Life: Alyx, which was developed exclusively for virtual reality headsets. It is a prequel set five years before Half-Life 2, where players control Freeman's eventual ally Alyx Vance in her quest to rescue her father from Combine forces and uncover their mysterious "super-weapon". The Half-Life series is recognized by critics and industry experts for producing some of the most influential first-person shooter games for the genre, both of which have been highlighted for their advancements towards immersive and varied gameplay, level design, storytelling, visuals and sound. Half-Life and Half-Life 2, as well as Portal and Portal 2, have in particular been cited by numerous publications in being considered among the greatest video games ever made.
===== Australia ===== Epilim Crushable Tablets Sanofi Epilim Sugar Free Liquid Sanofi Epilim Syrup Sanofi Epilim Tablets Sanofi Sodium Valproate Sandoz Tablets Sanofi Valpro Tablets Alphapharm Valproate Winthrop Tablets Sanofi Valprease tablets Sigma
In 1969, the dictator Francisco Franco designated Juan Carlos de Borbón as his successor "by title of king" with the title of Prince of Spain, by virtue of the Law of Succession to the Headship of the State of 1947. After Franco's death on November 20, 1975, the Regency Council assumed interim rule. Two days later, Juan Carlos I was proclaimed king before the Francoist Cortes. He delivered a speech in which he avoided referencing Franco's triumph in the Spanish Civil War and in which, after expressing his "respect and gratitude" to Franco, he stated that he intended to reach "an effective consensus of national concord". In this way, he made it clear that he did not support the pure "immobilist continuism" advocated by the búnker ─ which defended the perpetuation of Francoism under the monarchy established by Franco, following the model established in the Organic Law of the State of 1967─ but with a message to the Army to face the future with "serene tranquility" that hinted that the reform would be made from the regime's own institutions. The most enthusiastic round of applause from the Cortes, however, was not for the new king but for Franco's family present at the ceremony. The anti-Franco opposition received the king's speech with coldness. The ratification of Carlos Arias Navarro as President of the Government caused enormous disappointment, barely mitigated by the appointment of Torcuato Fernández Miranda, former tutor to the prince, as the new President of the Cortes and of the Council of the Realm, key institutions in the framework left by the Franco dictatorship.
=== Health history === A patient's health history may include disorders that affect the body's ability to heal itself. These disorders are called comorbidities and may interfere with circulatory and metabolic body functions, levels of various physiological assessment components (sugar, albumin, etc.), and induce other factors that negatively affect the healing. Common co-morbidities are: diabetes, venous insufficiency or peripheral arterial disease, respiratory and cardiovascular disorders, malignancies and autoimmune disorders.
Sources: en.wikipedia.org
In drug manufacture, validation is a documented process to ensure a product meets its required specifications and quality. The process of establishing documentary evidence demonstrating that a procedure, process, or activity carried out in testing and then production maintains the desired level of compliance at all stages. In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results. The desired results are established in terms of specifications for outcome of the process. Qualification of systems and equipment is therefore a part of the process of validation. Validation is a requirement of food, drug and pharmaceutical regulating agencies such as the US FDA and their good manufacturing practices guidelines. Since a wide variety of procedures, processes, and activities need to be validated, the field of validation is divided into a number of subsections including the following:
Freeman's sole film release of 2010 was Red with co-stars Bruce Willis, Helen Mirren, and John Malkovich. Red is loosely adapted from the comic-book series Red, created by Warren Ellis and Cully Hamner and published by the DC Comics imprint Homage. Freeman plays CIA mentor Joe, who helps retired fellow agent Frank (Willis) to uncover some assassins. The film was a critical and commercial success; writing for Melbourne's The Age, Jim Schembri praised Freeman and the cast who "bring an infectious comic energy to their roles". Besides film, Freeman worked on other projects. In January 2010, he replaced Walter Cronkite as the voiceover introduction to the CBS Evening News presented by Katie Couric. CBS gave the need for consistency in introductions for regular news broadcasts and special reports as the basis for the change. Deborah Myers, head of Science Channel, approached Freeman to be the presenter of Through the Wormhole (2010–17). She had heard that he was "really interested in space and the universe", and the pair agreed to develop the series together. In 2011, Freeman narrated the fantasy Conan the Barbarian and appeared in the family drama Dolphin Tale, as prosthetic specialist Dr. McCarthy. Returning to theater in 2011, Freeman was featured with John Lithgow in the Broadway debut of Dustin Lance Black's play, 8, a staged reenactment of Perry v. Brown, the federal trial that overturned California's Proposition 8 ban on same-sex marriage. Freeman played Attorney David Boies.
Body pain, arthralgia, myalgia Chronic fatigue and insomnia Depression, anxiety and mood disorders Gastrointestinal complications such as constipation, diarrhea, and acid reflux Weight gain or loss Frequent infections
Malcolm H. Kerr first coined the term "Arab Cold War" to refer to a political conflict inside the Arab world between Nasserist republics defending Arab socialism, Pan-Arabism, and Arab nationalism led by Nasser's Egypt, against traditionalist monarchies led by Saudi Arabia. An Atlantic Council member Bilal Y. Saab, an About.com writer Primoz Manfreda, an Iranian scholar Seyyed Hossein Mousavian and a Princeton University scholar Sina Toossi, journalist Kim Ghattas, Foreign Policy journalist Yochi Dreazen, Brookings Institution researcher Sultan Barakat, and Newsweek journalist Jonathan Broder use the term "cold war" to refer to tensions between Saudi Arabia and Iran. In February 2016, a University of Isfahan professor Ali Omidi dismissed the assumptions that the conflict between Iran and Saudi Arabia would grow tense.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
No. Major drug regulators have not approved GW501516 for treating any medical condition. Products sold as cardarine are typically unapproved research chemicals or supplements, so their contents and safety are not assured.